09 May 2024
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting
|
20101025 Health Services |
Other subject |
09 May 2024
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis Group NV brengt een update rond de publicatie van haar jaarverslag en de jaarlijkse algemene vergadering
|
20101025 Health Services |
Other subject |
10 Jan 2024
23:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)
|
20101025 Health Services |
Other subject |
10 Jan 2024
23:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)
|
20101025 Health Services |
Other subject |
22 Nov 2023
10:00 CET |
BIOCARTIS |
Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
|
20101025 Health Services |
Other subject |
13 Nov 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting
|
20101025 Health Services |
Other subject |
31 Oct 2023
15:55 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: Mededeling betreffende uitwinning door gewaarborgde schuldeisers
|
20101025 Health Services |
Other subject |
31 Oct 2023
15:55 CET |
BIOCARTIS |
Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors
|
20101025 Health Services |
Other subject |
20 Oct 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Vier abstracts, die uitstekende resultaten voor Idylla™ tonen, worden gepresenteerd op het European Society of Molecular Oncology (ESMO) congres
|
20101025 Health Services |
Other subject |
20 Oct 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)
|
20101025 Health Services |
Other subject |
16 Oct 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio
|
20101025 Health Services |
Other subject |
16 Oct 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis steunt Borstkankermaand met lancering van een borstkankerportfolio
|
20101025 Health Services |
Other subject |
12 Oct 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit
|
20101025 Health Services |
Other subject |
12 Oct 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt uitbreiding aan van de samenwerking met APIS Assay Technologies en zal de APIS ESR1 Mutations Kit commercialiseren
|
20101025 Health Services |
Other subject |
03 Oct 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
03 Oct 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Overeenkomst betreffende herkapitalisatie van operationele dochteronderneming door gewaarborgde schuldeisers en liquidatie van beursgenoteerde holdingmaatschappij
|
20101025 Health Services |
Other subject |
26 Sep 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt resultaten H1 2023 aan en geeft een update over de operationele reorganisatie en herkapitalisatie
|
20101025 Health Services |
Other subject |
21 Sep 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Webcast 2023 halfjaarresultaten Biocartis op 26 september 2023
|
20101025 Health Services |
Other subject |
21 Sep 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023
|
20101025 Health Services |
Other subject |
28 Aug 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis stelt nieuwe Medische Adviesraad (MAR) aan van vooraanstaande medische experts
|
20101025 Health Services |
Other subject |
28 Aug 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders
|
20101025 Health Services |
Other subject |
24 Aug 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt 2023 Halfjaarresultaten aan op 26 september 2023
|
20101025 Health Services |
Other subject |
24 Aug 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023
|
20101025 Health Services |
Other subject |
10 Aug 2023
07:00 CEST |
BIOCARTIS |
Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform
|
20101025 Health Services |
Other subject |
10 Aug 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis collaboreert met Lilly om biomarkertests op het Idylla™ Platform te onderzoeken voor NSCLC patiënten
|
20101025 Health Services |
Other subject |
18 Jul 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service Delivery
|
20101025 Health Services |
Other subject |
18 Jul 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis benoemt George Cardoza als nieuwe CFO en Hoofd Service Delivery
|
20101025 Health Services |
Other subject |
30 Jun 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Other subject |
30 Jun 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Other subject |
20 Jun 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
20 Jun 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
15 Jun 2023
17:15 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction program
|
20101025 Health Services |
Other subject |
15 Jun 2023
17:15 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt geplande operationele reorganisatie en kostenverminderingsprogramma aan
|
20101025 Health Services |
Other subject |
08 Jun 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
|
20101025 Health Services |
Other subject |
08 Jun 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of transparency notification
|
20101025 Health Services |
Other subject |
05 Jun 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis kondigt vertrek CFO aan
|
20101025 Health Services |
Other subject |
05 Jun 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis announces resignation CFO
|
20101025 Health Services |
Other subject |
12 May 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Resultaten van de Jaarlijkse Algemene Aandeelhoudersvergadering gehouden op 12 mei 2023
|
20101025 Health Services |
General meeting / Board Meeting |
12 May 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023
|
20101025 Health Services |
General meeting / Board Meeting |
09 May 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test
|
20101025 Health Services |
News contracts |
09 May 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis en HiloProbe gaan samenwerken op darmkankertest
|
20101025 Health Services |
News contracts |
28 Apr 2023
17:40 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
|
20101025 Health Services |
Change in Capital |
28 Apr 2023
17:40 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
|
20101025 Health Services |
Change in Capital |
20 Apr 2023
07:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023
|
20101025 Health Services |
Commercial results |
20 Apr 2023
07:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis rapporteert resultaten eerste kwartaal 2023
|
20101025 Health Services |
Commercial results |
11 Apr 2023
22:00 CEST |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO
|
20101025 Health Services |
Other subject |
11 Apr 2023
22:00 CEST |
BIOCARTIS |
Persbericht Biocartis Group NV: Biocartis benoemt Roger Moody als nieuwe CEO
|
20101025 Health Services |
Other subject |